The global biophotonics market size accounted for US$ 68.25 billion in 2023 and is projected to reach around USD 182.74 billion by 2033, growing at a CAGR of 10.35% from 2024 to 2033.
Key Points
- North America region has contributed the largest share of 38% in 2023.
- Asia-Pacific region is estimated to expand at the fastest CAGR of 13.54% during the forecast period.
- By end-use, the medical diagnostics segment has held the largest market share of 66% in 2023.
- By end-use, the non-medical application segment is anticipated to grow at a remarkable CAGR of 13.27% during the forecast period.
- By technology, the in-vitro segment has generated the largest market share of 59% in 2023.
- By technology, the in-vivo segment is expected to expand at the fastest CAGR of 11% over the projected period.
- By application, the analytics sensing segment has accounted more than 24% market share in 2023.
- By application, the see-through imaging segment is expected to expand at the fastest CAGR over the projected period.
Report Summary
The global biophotonics market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the biophotonics market across the globe.
A comprehensive estimate on the biophotonics market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of biophotonics during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3879
Biophotonics Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 10.35% |
| Global Market Size in 2023 | USD 68.25 Billion |
| Global Market Size by 2033 | USD 182.74 Billion |
| U.S. Market Size in 2023 | USD 19.45 Billion |
| U.S. Market Size by 2033 | USD 52.08 Billion |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By End-use, By Technology, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized biophotonics market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Used Truck Market Size to Worth USD 109.50 Billion by 2033
Market Players
The report includes the profiles of key biophotonics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Recent Developments
- In April 2021, the Indian government initiated the Production Linked Incentive Scheme (PLI 2.0) with the objective of fostering India’s manufacturing capabilities in the in vitro diagnostics sector. The scheme seeks to encourage increased investment and output, aiming to cultivate global players originating from India who can leverage modern technology to expand and integrate into global value chains.
- In March 2021, Zeiss bolstered its presence in North America through the inauguration of a new research and development, production, sales, and customer service center in the United States, involving a substantial investment of USD 180 million. This facility will house the X-ray Microscopy business and the ZEISS Microscopy Customer Center, providing comprehensive support for endeavors in materials research, life sciences, and industrial applications.
- In November 2021, Oxford Instruments introduced the BC43, a compact microscopy device capable of delivering real-time 3D imaging to users.
Biophotonics Market Companies
- Thermo Fisher Scientific Inc.
- Hamamatsu Photonics K.K.
- Olympus Corporation
- PerkinElmer Inc.
- Becton, Dickinson and Company
- Carl Zeiss AG
- Andor Technology Ltd.
- Affymetrix, Inc.
- Bruker Corporation
- Newport Corporation
- Nikon Corporation
- Coherent, Inc.
- Idex Corporation
- Lumenis Ltd.
- Corning Incorporated
Segments Covered in the Report
By End-use
- Tests and Components
- Medical Therapeutics
- Medical Diagnostics
- Non-medical Application
By Technology
- In-Vitro
- In-Vivo
By Application
- See-Through imaging
- Microscopy
- Inside Imaging
- Spectro Molecular
- Analytics sensing
- Light therapy
- Surface imaging
- Biosensors
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Biophotonics Market
5.1. COVID-19 Landscape: Biophotonics Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Biophotonics Market, By End-use
8.1. Biophotonics Market, by End-use, 2024-2033
8.1.1 Tests and Components
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Medical Therapeutics
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Medical Diagnostics
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Non-medical Application
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Biophotonics Market, By Technology
9.1. Biophotonics Market, by Technology, 2024-2033
9.1.1. In-Vitro
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. In-Vivo
9.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Biophotonics Market, By Application
10.1. Biophotonics Market, by Application, 2024-2033
10.1.1. See-Through imaging
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Microscopy
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Inside Imaging
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Spectro Molecular
10.1.4.1. Market Revenue and Forecast (2021-2033)
10.1.5. Analytics sensing
10.1.5.1. Market Revenue and Forecast (2021-2033)
10.1.6. Light therapy
10.1.6.1. Market Revenue and Forecast (2021-2033)
10.1.7. Surface imaging
10.1.7.1. Market Revenue and Forecast (2021-2033)
10.1.8. Biosensors
10.1.8.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Biophotonics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by End-use (2021-2033)
11.1.2. Market Revenue and Forecast, by Technology (2021-2033)
11.1.3. Market Revenue and Forecast, by Application (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.1.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.1.5.3. Market Revenue and Forecast, by Application (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by End-use (2021-2033)
11.2.2. Market Revenue and Forecast, by Technology (2021-2033)
11.2.3. Market Revenue and Forecast, by Application (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.2.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.2.5.3. Market Revenue and Forecast, by Application (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by End-use (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Technology (2021-2033)
11.2.6.3. Market Revenue and Forecast, by Application (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by End-use (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Technology (2021-2033)
11.2.7.3. Market Revenue and Forecast, by Application (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by End-use (2021-2033)
11.3.2. Market Revenue and Forecast, by Technology (2021-2033)
11.3.3. Market Revenue and Forecast, by Application (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.3.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.3.5.3. Market Revenue and Forecast, by Application (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by End-use (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Technology (2021-2033)
11.3.6.3. Market Revenue and Forecast, by Application (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by End-use (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Technology (2021-2033)
11.3.7.3. Market Revenue and Forecast, by Application (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.4.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.4.5.3. Market Revenue and Forecast, by Application (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by End-use (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Technology (2021-2033)
11.4.6.3. Market Revenue and Forecast, by Application (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by End-use (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Technology (2021-2033)
11.4.7.3. Market Revenue and Forecast, by Application (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.5.3. Market Revenue and Forecast, by Application (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by End-use (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Technology (2021-2033)
11.5.4.3. Market Revenue and Forecast, by Application (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by End-use (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Technology (2021-2033)
11.5.5.3. Market Revenue and Forecast, by Application (2021-2033)
Chapter 12. Company Profiles
12.1. Thermo Fisher Scientific Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Hamamatsu Photonics K.K.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Olympus Corporation
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. PerkinElmer Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Becton, Dickinson and Company
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Carl Zeiss AG
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Andor Technology Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Affymetrix, Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Bruker Corporation
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Newport Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
